Xpanceo raised a $250 million funding round, which elevates its valuation to $1.35 billion, as it pioneers smart contact ...

LENZ Therapeutics (LENZ) said Monday that CORXEL Pharmaceuticals has submitted the new drug application for LNZ100 to the Center for Drug Evaluation of the National Medical Products Administration of ...